{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:18:58Z","timestamp":1788434338304,"version":"build-2803163510"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"34","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277084"],"award-info":[{"award-number":["22277084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477087"],"award-info":[{"award-number":["22477087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0754"],"award-info":[{"award-number":["2024NSFSC0754"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>BRAF is the most frequently mutated protein kinase in human cancers, and in particular, the V600E mutation in the kinase domain confers a constitutively active conformation on the protein, thereby promoting oncogenesis. To date, several BRAF kinase inhibitors have been approved for treating cancer patients with the BRAF(V600E) mutation. However, the benefits of BRAF kinase inhibitors in clinical practice are limited, with an objective response rate of less than \u223c50%. Therefore, novel diagnostic tools enabling the visualization of BRAF-mutant activity in an activity-based manner are quite desirable to determine BRAF-mutant status and guide treatment decisions for BRAF inhibitors. Here, we describe the design, synthesis, and application of a new fluorescence-enhanced probe HX50 by introducing an environment-sensitive fluorophore to the pharmacophore of BRAF inhibitors to visualize BRAF kinase activity in living cancer cells and tumor tissues (mouse models and human tumor biopsy samples). Interestingly, we found that the probe enables distinguishing the BRAF(V600E) mutation from the wild type not only in living cancer cells but also in xenograft mouse models. Furthermore, the fluorescence-enhanced probe was also able to visualize BRAF activity with high signal contrast in human tumors from lung cancer patients carrying the BRAF(V600E) mutation, but not BRAF wild-type. These results demonstrate that the strategically designed drug-based fluorescence-enhanced probe enables assessment of BRAF-mutant activity in tumor samples and holds promise as a useful diagnostic tool for predicting drug sensitivity and informing therapeutic strategy decisions for BRAF inhibitors.<\/jats:p>","DOI":"10.1021\/acs.analchem.6c03277","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:01:22Z","timestamp":1786741282000},"page":"25186-25198","source":"Crossref","is-referenced-by-count":0,"title":["A Fluorescence-Enhanced\nProbe Enables Rapid Detection\nof BRAF(V600E) Mutant Activity in Living Cells and Tumor Tissues"],"prefix":"10.1021","volume":"98","author":[{"given":"Qian","family":"Lei","sequence":"first","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Qi","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panwen","family":"Tian","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2047-3441","authenticated-orcid":true,"given":"Mingyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0899-4188","authenticated-orcid":true,"given":"Hui","family":"Deng","sequence":"additional","affiliation":[{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]},{"name":"Sichuan University , , ,","place":["Chengdu, China, 610041"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"1","key":"2026090306472248900_cit1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bjc.2017.399","article-title":"Targeting the Raf Kinases in Human Cancer: The Raf\nDimer Dilemma","volume":"118","author":"Durrant","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"14","key":"2026090306472248900_cit2","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1002\/cam4.3103","article-title":"BRAF Mutation\nand Its Inhibitors in Sarcoma Treatment","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer\nMed."},{"issue":"2","key":"2026090306472248900_cit3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/13543784.2019.1558442","article-title":"BRAF Kinase Inhibitors\nfor Treatment of Melanoma: Developments from Early-Stage Animal Studies\nto Phase II Clinical Trials","volume":"28","author":"Fujimura","year":"2019","journal-title":"Expert Opin. Investig.\nDrugs"},{"issue":"7287","key":"2026090306472248900_cit4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF Inhibitors\nTransactivate RAF Dimers and ERK Signalling in Cells with Wild-Type\nBRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"issue":"6892","key":"2026090306472248900_cit5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF Gene in Human\nCancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"5","key":"2026090306472248900_cit6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF Protein\nKinases in ERK Signalling","volume":"16","author":"Lavoie","year":"2015","journal-title":"Nat. Rev. Mol. Cell\nBiol."},{"issue":"8","key":"2026090306472248900_cit7","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1021\/acs.jmedchem.9b02083","article-title":"Discovery of Selective Small Molecule\nDegraders of BRAF-V600E","volume":"63","author":"Han","year":"2020","journal-title":"J. Med. Chem."},{"issue":"6","key":"2026090306472248900_cit8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1158\/0008-5472.CAN-17-2033","article-title":"Antitumor\nProperties of RAF709, a Highly Selective and Potent Inhibitor of RAF\nKinase Dimers, in Tumors Driven by Mutant RAS or BRAF","volume":"78","author":"Shao","year":"2018","journal-title":"Cancer Res."},{"issue":"7315","key":"2026090306472248900_cit9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical Efficacy of a RAF Inhibitor\nNeeds Broad Target Blockade in BRAF-Mutant Melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"issue":"4","key":"2026090306472248900_cit10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","article-title":"Guilty as Charged:\nB-RAF Is a Human Oncogene","volume":"6","author":"Garnett","year":"2004","journal-title":"Cancer Cell"},{"issue":"24","key":"2026090306472248900_cit11","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying\nBRAF Alterations in Cancer: New Rational Therapeutic Strategies for\nActionable Mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"key":"2026090306472248900_cit12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular Targeted Therapy: Treating\nCancer with Specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"2026090306472248900_cit13","doi-asserted-by":"publisher","DOI":"10.7603\/s40681-015-0019-4","article-title":"An Overview\nof Targeted Cancer Therapy","volume":"5","author":"Padma","year":"2015","journal-title":"BioMedicine"},{"issue":"7793","key":"2026090306472248900_cit14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-Cancer Analysis of Whole Genomes","volume":"578","author":"Aaltonen","year":"2020","journal-title":"Nature"},{"issue":"9839","key":"2026090306472248900_cit15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-Mutated\nMetastatic Melanoma: A Multicentre,\nOpen-Label, Phase 3 Randomised Controlled Trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet London Engl."},{"issue":"3","key":"2026090306472248900_cit16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS Mutations in Cutaneous\nSquamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"2026090306472248900_cit17","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK\nInhibition in Melanoma with BRAF V600 Mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"2026090306472248900_cit18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF\nand MEK Inhibition versus BRAF Inhibition Alone in Melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2026090306472248900_cit19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00268","article-title":"Diverse Mechanisms\nof BRAF Inhibitor Resistance in\nMelanoma Identified in Clinical and Preclinical Studies","volume":"9","author":"Luebker","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"2026090306472248900_cit20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02350-8","article-title":"Differential Responsiveness to BRAF Inhibitors of Melanoma Cell Lines\nBRAF V600E-Mutated","volume":"18","author":"Al Hashmi","year":"2020","journal-title":"J. Transl. Med."},{"issue":"13","key":"2026090306472248900_cit21","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1039\/D0CS01096K","article-title":"NBD-Based Synthetic Probes for Sensing\nSmall Molecules and Proteins: Design, Sensing Mechanisms and Biological\nApplications","volume":"50","author":"Jiang","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"24","key":"2026090306472248900_cit22","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1039\/D1SC01359A","article-title":"Recent Advances in Activity-Based\nProbes (ABPs) and\nAffinity-Based Probes (AfBPs) for Profiling of Enzymes","volume":"12","author":"Fang","year":"2021","journal-title":"Chem. Sci."},{"issue":"19","key":"2026090306472248900_cit23","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1021\/jacs.7b11281","article-title":"Selective\nPhotoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells","volume":"140","author":"Soethoudt","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"2026090306472248900_cit24","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202216142","article-title":"Fluorogenic Granzyme A Substrates\nEnable Real-Time\nImaging of Adaptive Immune Cell Activity","volume":"62","author":"Cheng","year":"2023","journal-title":"Angew.\nChem., Int. Ed."},{"issue":"41","key":"2026090306472248900_cit25","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202207508","article-title":"Enzyme-Activatable\nChemokine Conjugates for In Vivo Targeting of Tumor-Associated Macrophages","volume":"61","author":"Barth","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"2026090306472248900_cit26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34627-5","article-title":"A Fluorogenic Probe for Predicting\nTreatment Response in Non-Small Cell Lung Cancer with EGFR-Activating\nMutations","volume":"13","author":"Deng","year":"2022","journal-title":"Nat. Commun."},{"issue":"37","key":"2026090306472248900_cit27","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1039\/c3ob40776d","article-title":"Synthesis, Biological\nEvaluation and Molecular Docking of Novel 5-Phenyl-1H-Pyrazol Derivatives\nas Potential BRAFV600E Inhibitors","volume":"11","author":"Dong","year":"2013","journal-title":"Org. Biomol.\nChem."},{"key":"2026090306472248900_cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112901","article-title":"Design and Synthesis\nof Novel Fluorescently Labeled Analogs of Vemurafenib Targeting MKK4","volume":"209","author":"Kircher","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"2026090306472248900_cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115446","article-title":"A Cyanine-Based\nNIR Fluorescent Vemurafenib Analog to Probe BRAFV600E in Cancer Cells","volume":"256","author":"Barresi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"2026090306472248900_cit30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.7150\/thno.18238","article-title":"Design and\nDevelopment of Fluorescent Vemurafenib Analogs for In Vivo Imaging","volume":"7","author":"Mikula","year":"2017","journal-title":"Theranostics"},{"issue":"24","key":"2026090306472248900_cit31","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1158\/1078-0432.CCR-11-1155","article-title":"Role of BRAF in Thyroid Oncogenesis","volume":"17","author":"Caronia","year":"2011","journal-title":"Clin. Cancer Res."}],"container-title":["Analytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.analchem.6c03277","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/34\/25186\/66568753\/acs.analchem.6c03277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancham\/article-pdf\/98\/34\/25186\/66568753\/acs.analchem.6c03277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:47:26Z","timestamp":1788432446000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancham\/article\/98\/34\/25186\/5256822\/A-Fluorescence-Enhanced-Probe-Enables-Rapid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":31,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.analchem.6c03277","relation":{},"ISSN":["0003-2700","1520-6882"],"issn-type":[{"value":"0003-2700","type":"print"},{"value":"1520-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}